Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and

Infection and Immunity
|November 1, 1971
PubMed

Insights

Polymyxin B sulfate effectively neutralized endotoxin toxicity in rabbits, preventing leukopenia and thrombocytopenia. Colymycin M showed some effect, while gentamicin sulfate did not neutralize endotoxin effects.

Area of Science:

  • Pharmacology
  • Microbiology
  • Toxicology

Background:

  • Endotoxins are potent toxins released from bacteria.
  • Endotoxins can cause severe systemic effects, including disseminated intravascular coagulation.
  • Antimicrobial agents are investigated for potential endotoxin-neutralizing properties.

Purpose of the Study:

  • To evaluate the efficacy of three antimicrobial agents in neutralizing endotoxin toxicity.
  • To compare the neutralizing capabilities of polymyxin B sulfate, colymycin M, and gentamicin sulfate against endotoxin effects in a rabbit model.

Main Methods:

  • Rabbits were administered endotoxin to induce toxic effects.
  • The ability of polymyxin B sulfate, colymycin M (sodium colistimethate), and gentamicin sulfate to counteract these effects was assessed.
  • Key indicators monitored included leukopenia, thrombocytopenia, and disseminated intravascular coagulation.

Main Results:

  • Polymyxin B sulfate consistently prevented endotoxin-induced leukopenia, thrombocytopenia, and disseminated intravascular coagulation.
  • Colymycin M exhibited similar protective activity but was less potent than polymyxin B sulfate.
  • Gentamicin sulfate demonstrated no significant endotoxin-neutralizing activity in this experimental setup.

Conclusions:

  • Polymyxin B sulfate is a highly effective agent for neutralizing endotoxin toxicity in rabbits.
  • Colymycin M offers partial protection against endotoxin effects.
  • Gentamicin sulfate is ineffective in neutralizing endotoxin-induced toxicity in this model.